Literature DB >> 11237212

Intracellular organization of insulin signaling and GLUT4 translocation.

R T Watson1, J E Pessin.   

Abstract

Glucose is cleared from the bloodstream by a family of facilitative transporters (GLUTs), which catalyze the transport of glucose down its concentration gradient and into cells of target tissues, primarily striated muscle and adipose. Currently, there are five established functional facilitative glucose transporter isoforms (GLUT1-4 and GLUTX1), with GLUT5 being a fructose transporter. GLUT1 is ubiquitously expressed with particularly high levels in human erythrocytes and in the endothelial cells lining the blood vessels of the brain. GLUT3 is expressed primarily in neurons and, together, GLUT1 and GLUT3 allow glucose to cross the blood-brain barrier and enter neurons. GLUT2 is a low-affinity (high Km) glucose transporter present in liver, intestine, kidney, and pancreatic beta cells. This transporter functions as part of the glucose sensor system in beta cells and in the basolateral transport of intestinal epithelial cells that absorb glucose from the diet. A new facilitative glucose transporter protein, GLUTX1, has been identified and appears to be important in early blastocyst development. The GLUT4 isoform is the major insulin-responsive transporter that is predominantly restricted to striated muscle and adipose tissue. In contrast to the other GLUT isoforms, which are primarily localized to the cell surface membrane, GLUT4 transporter proteins are sequestered into specialized storage vesicles that remain within the cell's interior under basal conditions. As postprandial glucose levels rise, the subsequent increase in circulating insulin activates intracellular signaling cascades that ultimately result in the translocation of the GLUT4 storage compartments to the plasma membrane. Importantly, this process is readily reversible such that when circulating insulin levels decline, GLUT4 transporters are removed from the plasma membrane by endocytosis and are recycled back to their intracellular storage compartments. Therefore, by establishing an internal membrane compartment as the default localization for the GLUT4 transporters, insulin-responsive tissues are poised to respond rapidly and efficiently to fluctuations in circulating insulin levels. Unfortunately, the complexity of these regulatory processes provides numerous potential targets that may be defective and eventually result in peripheral tissue insulin resistance and possibly diabetes. As such, understanding the molecular details of GLUT4 expression, GLUT4 vesicle compartment biogenesis, GLUT4 sequestration, vesicle trafficking, and fusion with the plasma membrane has become a major focus for many laboratories. This chapter will focus on recently elucidated insulin signal transduction pathways and GLUT4 vesicle trafficking components that are necessary for insulin-stimulated glucose uptake and GLUT4 translocation in adipocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237212     DOI: 10.1210/rp.56.1.175

Source DB:  PubMed          Journal:  Recent Prog Horm Res        ISSN: 0079-9963


  53 in total

1.  Entry of newly synthesized GLUT4 into the insulin-responsive storage compartment is GGA dependent.

Authors:  Robert T Watson; Ahmir H Khan; Megumi Furukawa; June Chunqiu Hou; Lin Li; Makoto Kanzaki; Shuichi Okada; Konstantin V Kandror; Jeffrey E Pessin
Journal:  EMBO J       Date:  2004-04-29       Impact factor: 11.598

2.  Modulation of muscle regeneration, myogenesis, and adipogenesis by the Rho family guanine nucleotide exchange factor GEFT.

Authors:  Brad A Bryan; Dianne C Mitchell; Lei Zhao; Wenbin Ma; Lewis J Stafford; Ba-Bie Teng; Mingyao Liu
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

3.  Golgin-160 is required for the Golgi membrane sorting of the insulin-responsive glucose transporter GLUT4 in adipocytes.

Authors:  Dumaine Williams; Stuart W Hicks; Carolyn E Machamer; Jeffrey E Pessin
Journal:  Mol Biol Cell       Date:  2006-10-18       Impact factor: 4.138

4.  Activation of a novel calcineurin-mediated insulin-like growth factor-1 receptor pathway, altered metabolism, and tumor cell invasion in cells subjected to mitochondrial respiratory stress.

Authors:  Manti Guha; Satish Srinivasan; Gopa Biswas; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2007-03-13       Impact factor: 5.157

5.  Development of Wistar rat model of insulin resistance.

Authors:  Jing Ai; Ning Wang; Mei Yang; Zhi-Min Du; Yong-Chun Zhang; Bao-Feng Yang
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

6.  Crystal structure of a glucose/H+ symporter and its mechanism of action.

Authors:  Cristina V Iancu; Jamillah Zamoon; Sang Bum Woo; Alexander Aleshin; Jun-yong Choe
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

7.  Isolation of sarcolemmal plasma membranes by mechanically skinning rat skeletal muscle fibers for phospholipid analysis.

Authors:  Val Andrew Fajardo; Lauren McMeekin; Admir Basic; Graham D Lamb; Robyn M Murphy; Paul J LeBlanc
Journal:  Lipids       Date:  2013-02-22       Impact factor: 1.880

8.  Keratinocyte growth factor-2 stimulates P-glycoprotein expression and function in intestinal epithelial cells.

Authors:  Seema Saksena; Shubha Priyamvada; Anoop Kumar; Maria Akhtar; Vikas Soni; Arivarasu Natarajan Anbazhagan; Anas Alakkam; Waddah A Alrefai; Pradeep K Dudeja; Ravinder K Gill
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-01-17       Impact factor: 4.052

9.  Activation of protein kinase C zeta induces serine phosphorylation of VAMP2 in the GLUT4 compartment and increases glucose transport in skeletal muscle.

Authors:  L Braiman; A Alt; T Kuroki; M Ohba; A Bak; T Tennenbaum; S R Sampson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  Endothelial inflammation induced by excess glucose is associated with cytosolic glucose 6-phosphate but not increased mitochondrial respiration.

Authors:  I R Sweet; M Gilbert; E Maloney; D M Hockenbery; M W Schwartz; F Kim
Journal:  Diabetologia       Date:  2009-02-14       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.